I was a bit surprised that Amrit was so disparaging toward advocacy groups not working together...I see the exact opposite thing happening. Then, along comes Cindy Bateman spoon-feeding the federal government with a healthcare model she's investigated by way of her non-profit...when federal agencies should have the institutional knowledge to make propose these changes. Imagine if Cindy Bateman were in a federal appointment...she's so productive...glad she's on Team ME!
So true...but at least it sounds like she is busy at work. She does have industry contacts. At the same time, no disease is perfectly profiled within its various subsets...all clinical trials have some element of problems with this.Arrghhhhh ......Amrit Shazhad is continued to lecture the patient community about "our lack of objectivity." That really torques me off. A lot of people have advocated 'objectively' for years to decades AND it's BECAUSE of that, COMBINED WITH PASSIONATE advocacy that has pushed the field forward.
It's the same-old blame the patients and put the onus of patient advocacy groups.
There has to be a balance of duties and responsibilities between patients, the government, nonprofits, academia, and industry. It's one thing to be "lectured" by government officials and others -- that's half-expected -- but we don't need that from our own side.
So true...but at least it sounds like she is busy at work. She does have industry contacts. At the same time, no disease is perfectly profiled within its various subsets...all clinical trials have some element of problems with this.
I think we're on the same page.I'm not annoyed at her for her work but she could have thanked the government officials and others WITHOUT the disparagement of patients and advocates. THAT was not needed nor is it helpful.
Have watched CFSAC meetings since inception & agree with @Sing it's worth a listen when the link is posted.This was a very good two-day session overall, which I recommend listening to in whole or part, when we get a link.
FWIW - Donna Pearson is a rockstar on CFSAC
Good question! The selection criteria are so strict, it makes one wonder who exactly they will be studying. Also, since one must not be sick for longer than 5 years, I'm going to guess that autoimmunity will not be as strongly expressed as it might be in longer-term sufferers.@Emily Taylor would it be possible for you to give us some more detail on Carol Head's "Public Comments" about study participant selection criteria for NIH's ME/CFS intramural study? Carol seemed concerned.
And it appears from NIH updates very few participants have been enrolled to date.